Acumen Pharmaceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | 39.4% | 39.4% | -16.5% |
| FY2021 | -44.7% | -44.7% | -43.7% |
| FY2022 | -22.7% | -22.7% | -21.8% |
| FY2023 | -19.6% | -17.6% | -16.9% |
| FY2024 | -56.3% | -48.4% | -42.8% |
| FY2025 | -172.3% | -130.7% | -98.8% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | 39.4% | 39.4% | -16.5% |
| FY2021 | -44.7% | -44.7% | -43.7% |
| FY2022 | -22.7% | -22.7% | -21.8% |
| FY2023 | -19.6% | -17.6% | -16.9% |
| FY2024 | -56.3% | -48.4% | -42.8% |
| FY2025 | -172.3% | -130.7% | -98.8% |